Jerome Brice has held various roles throughout their work experience. Jerome began their career with an internship at NM ROTHSCHILD & SONS in 2002. Jerome then worked at SFR-CEGETEL Group in the Regulation and Competition Division for a few months in 2004. From 2004 to 2007, they served as a Financial Analyst at Merrill Lynch. Jerome joined Valeo in 2007 and held multiple positions, including M&A Manager, Group Strategic Operations Director, and ultimately, CFO of the Comfort and Driving Assistance Systems Business Group. In this role, they oversaw cash management, financial accounts, internal control, tax efficiency, cost controls, resource allocations, and the budget and business plan processes. Jerome also played a key role in strategy planning and implementation, M&A operations, and team management. Jerome recently joined Ramsay Santé as the Group CFO in 2022.
Jerome Brice began their education in 1999 at École Polytechnique, where they pursued a degree without specifying the field of study. Jerome continued their academic journey at Mines Paris from 2002 to 2004, where they focused on Economics & Law.
This person is not in any offices
Ramsay Santé
1 followers
After the acquisition of the Capio Group in 2018, Ramsay Santé has become Europe's leading private hospital and primary care companies. The group now has 36,000 employees and works with nearly 8,600 private practitioners. Present in 5 countries, France, Sweden, Norway, Denmark and Italy, the group treats more than 7 million patients per year in its 350 establishments. In hospitalization, Ramsay Santé offers almost all medical and surgical treatments in three business lines: Medicine-Surgery-Obstetrics (MCO), Follow-up and Rehabilitation Care (SSR) and Mental Health. Wherever it is present, the group participates in public health service missions and in the health network of the country, as in Sweden where the group has more than a hundred local health centres. The quality and safety of care is the group's priority in all the countries where it operates. This is why the group is today one of the references in modern medicine, especially in ambulatory surgery and enhanced recovery after surgery (ARS). The group also invests more than €200 million every year in its establishments, whether in new surgical and imaging technologies, or in the construction and modernisation of establishments. It also innovates at the service of patients with new digital tools and by developing its organisations to improve the efficiency of care.